Eric Kuo, MD
Eric J. Kuo, MD is a board certified endocrine surgeon and Assistant Professor of Surgery who is skilled in the surgical treatment of thyroid, parathyroid, and adrenal disease.
Dr. Kuo has had the unique opportunity to train with a variety of national and international leaders in the field of endocrine surgery. After obtaining his medical degree from the Yale University School of Medicine, Dr. Kuo completed his general surgery residency at the University of California, Los Angeles before completing his fellowship training in Endocrine Surgery at Columbia University, where he was recruited to stay on as faculty.
Dr. Kuo’s clinical interests are in the surgical treatment of thyroid, parathyroid, and adrenal disease, including minimally invasive thyroid and parathyroid surgery, retroperitoneoscopic adrenalectomy and robotic adrenalectomy. His philosophy towards patient care includes compassion, shared decision making, and technically excellent surgery.
Dr. Kuo’s research interests include clinical outcomes and health services research, clinical informatics, and surgical education. His work has been published in high impact journals including Thyroid, JAMA Surgery, and Annals of Surgery and he has presented his work at national meetings including the American Thyroid Association and American Association of Endocrine Surgeons annual meetings.
E. Chester Ridgway Trainee Grant, American Thyroid Association, Victoria, British Columbia, 2017
Outstanding Student Teaching Award, University of California, Los Angeles, Los Angeles, CA, 2017
The Association for Academic Surgery—Novartis Research Award, Yale School of Medicine, New Haven, CT, 2014
Phi Beta Kappa, Junior, University of Southern California, Los Angeles, CA, 2008
Dean’s List, University of Southern California, Los Angeles, CA, 2005-2009
Livhits MJ, Zhu CY, Kuo EJ, Nguyen DT, Kim J, Tseng CH, Leung AM, Rao J, Levin M, Douek ML, Beckett KR, Cheung DS, Gofnung YA, Smooke-Praw S, Yeh MW. Effectiveness of Molecular Testing Techniques for Diagnosis of Indeterminate Thyroid Nodules: A Randomized Clinical Trial. JAMA Oncol. 2021 Jan 1;7(1):70-77. doi: 10.1001/jamaoncol.2020.5935. PMID: 33300952; PMCID: PMC7729582.
Yeh MW, Zhou H, Kuo EJ, Adams AL, Li N, Haigh PI. Biochemical Dynamics of Untreated Primary Hyperparathyroidism: An Observational Study. Endocrine Practice. 2019 May;25(5):470-476.
Lee JD, Kuo EJ, Du L, Yeh MW, Livhits MJ. Risk Factors for Readmission after Parathyroidectomy for Renal Hyperparathyroidism. World Journal of Surgery. 2019 Feb;43(2):534-539.
Assadipour Y, Zhou H, Kuo EJ, Haigh PI, Adams AL, Yeh MW. End-Organ Effects of Primary Hyperparathyroidism: A Population-Based Study. Annals of Surgical Oncology. 2019 Jan;165(1):99-104.
Sho S, Kuo EJ, Chen AC, Li N, Yeh MW, Livhits MJ. Biochemical and Skeletal Outcomes of Parathyroidectomy for Normocalcemic (Incipient) Primary Hyperparathyroidism. Annals of Surgical Oncology. 2019 Feb;26(2):539-546.